|SAN DIEGO--(BUSINESS WIRE)--Jan. 2, 2018--
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company
focused on the development and commercialization of innovative medicines
that address unmet medical needs in central nervous system disorders,
today announced that it will present at the 36th Annual J.P.
Morgan Healthcare Conference on Tuesday, January 9, 2018, at 1:30 p.m.
Pacific Time in San Francisco.
A live webcast of ACAD... |